vs

Side-by-side financial comparison of Alps Group Inc (ALPS) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.

Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $2.2M, roughly 1.0× Alps Group Inc).

Alps Group Inc is a global electronic components manufacturer offering automotive sensors, semiconductor parts, input devices, industrial components and healthcare electronic modules. It serves automotive, consumer electronics, industrial and healthcare segments across Asia, Europe and North America.

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

ALPS vs TIL — Head-to-Head

Bigger by revenue
TIL
TIL
1.0× larger
TIL
$2.2M
$2.2M
AL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
AL
ALPS
TIL
TIL
Revenue
$2.2M
$2.2M
Net Profit
$-8.2M
Gross Margin
42.0%
Operating Margin
-54.2%
-426.3%
Net Margin
-365.3%
Revenue YoY
-19.2%
Net Profit YoY
31.1%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AL
ALPS
TIL
TIL
Q4 25
$2.2M
Q3 25
$2.2M
$2.2M
Q2 25
$2.2M
Q1 25
$2.2M
Q4 24
$2.8M
Q3 24
$1.5M
Q2 24
$0
Q1 24
$0
Net Profit
AL
ALPS
TIL
TIL
Q4 25
$-8.2M
Q3 25
$-13.6M
Q2 25
$-21.4M
Q1 25
$-28.2M
Q4 24
$-11.9M
Q3 24
$-23.0M
Q2 24
$-14.9M
Q1 24
$-24.3M
Gross Margin
AL
ALPS
TIL
TIL
Q4 25
Q3 25
42.0%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
AL
ALPS
TIL
TIL
Q4 25
-426.3%
Q3 25
-54.2%
-670.0%
Q2 25
-1045.5%
Q1 25
-1363.2%
Q4 24
-426.1%
Q3 24
-1582.8%
Q2 24
Q1 24
Net Margin
AL
ALPS
TIL
TIL
Q4 25
-365.3%
Q3 25
-606.0%
Q2 25
-954.2%
Q1 25
-1257.8%
Q4 24
-428.8%
Q3 24
-1541.9%
Q2 24
Q1 24
EPS (diluted)
AL
ALPS
TIL
TIL
Q4 25
$-1.13
Q3 25
$-2.01
Q2 25
$-3.24
Q1 25
$-4.32
Q4 24
$-1.82
Q3 24
$-3.54
Q2 24
$-2.29
Q1 24
$-3.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AL
ALPS
TIL
TIL
Cash + ST InvestmentsLiquidity on hand
$6.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$113.9M
Total Assets
$203.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AL
ALPS
TIL
TIL
Q4 25
$6.6M
Q3 25
$5.8M
Q2 25
$7.7M
Q1 25
$15.4M
Q4 24
$8.8M
Q3 24
$6.7M
Q2 24
$6.8M
Q1 24
$5.5M
Stockholders' Equity
AL
ALPS
TIL
TIL
Q4 25
$113.9M
Q3 25
$120.4M
Q2 25
$131.7M
Q1 25
$144.9M
Q4 24
$169.4M
Q3 24
$176.3M
Q2 24
$195.0M
Q1 24
$205.8M
Total Assets
AL
ALPS
TIL
TIL
Q4 25
$203.5M
Q3 25
$211.8M
Q2 25
$231.0M
Q1 25
$237.4M
Q4 24
$263.6M
Q3 24
$272.6M
Q2 24
$294.3M
Q1 24
$306.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AL
ALPS
TIL
TIL
Operating Cash FlowLast quarter
$-731.7K
$-7.1M
Free Cash FlowOCF − Capex
$-804.3K
FCF MarginFCF / Revenue
-36.6%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AL
ALPS
TIL
TIL
Q4 25
$-7.1M
Q3 25
$-731.7K
$-10.6M
Q2 25
$-14.8M
Q1 25
$-4.2M
Q4 24
$-10.6M
Q3 24
$-20.1M
Q2 24
$-10.6M
Q1 24
$-14.4M
Free Cash Flow
AL
ALPS
TIL
TIL
Q4 25
Q3 25
$-804.3K
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
AL
ALPS
TIL
TIL
Q4 25
Q3 25
-36.6%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
AL
ALPS
TIL
TIL
Q4 25
Q3 25
3.3%
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons